Martti Nurmi

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial (2011)

Scandinavian Journal of Urology and Nephrology

Nurmi Martti

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Intact and Internally Cleaved Free Prostate-Specific Antigen in Patients With Prostate Cancer With Different Pathologic Stages and Grades (2011)

Urology

Peltola MT, Niemela P, Vaisanen V, Viitanen T, Alanen K, Nurmi M, Pettersson K

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy. (2010)

Journal of Nuclear Medicine

Jambor Ivan, Borra Ronald, Kemppainen Jukka, Lepomäki Virva, Parkkola Ritta, Dean Kirsti, Alanen Kalle, Arponen Evellina, Nurmi Martti, Aronen Hannu Juhani, Minn Heikki

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells (2010)

International Journal of Biochemistry and Cell Biology

Dagvadorj A, Tan S H, Liao Z, Xie J, Nurmi M, Alanen K, Rui H, Mirtti T, Nevalainen M T

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Publications

Sort by:

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial (2011)

Intact and Internally Cleaved Free Prostate-Specific Antigen in Patients With Prostate Cancer With Different Pathologic Stages and Grades (2011)

Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy. (2010)

N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells (2010)